AccessHope

About AccessHope

AccessHope operates as a wholly-owned subsidiary of City of Hope, a world-renowned cancer research and treatment center. Founded in 2019 and formally launched in October 2020, AccessHope was established to export the specialized knowledge of National Cancer Institute (NCI)-designated comprehensive cancer centers to a broader audience. The company was created with an initial investment of over $40 million from City of Hope to address the gap between cutting-edge cancer research and the care delivered in local communities. In April 2024, AccessHope secured an additional $33 million in a Series B funding round from City of Hope to facilitate its growth as a stand-alone commercial entity.

The company's business model is centered on providing cancer support services as an employer-sponsored health benefit, integrating with employers' existing health plans, third-party administrators, and pharmacy benefit managers. AccessHope's clients are primarily large, self-funded employers, and as of April 2024, the company serves nearly seven million members across more than 400 organizations, including over 60 Fortune 500 companies. Revenue is generated on a Per Employee Per Month (PEPM) basis or through utilization-based invoicing. The core of the business is to connect employees and their local community oncologists with subspecialists from its network of elite cancer centers, which includes City of Hope, Dana-Farber Cancer Institute, Johns Hopkins Medicine, and others. This remote collaboration allows patients to receive expert input on their diagnosis and treatment plan without needing to travel, ensuring they can stay close to their homes and support systems.

AccessHope provides a suite of services that do not involve direct medical care but rather offer decision support. Key offerings include: **Accountable Precision Oncology**, which uses a proprietary algorithm to identify complex cases that would most benefit from expert review; **Expert Advisory Review**, where a subspecialist reviews a patient's medical records and provides evidence-based recommendations to their local oncologist; and the **Cancer Support Team**, which consists of experienced oncology nurses who provide information and emotional support to patients and their families. By providing these services, AccessHope aims to ensure patients get on the right treatment path from the beginning, which can improve clinical outcomes and reduce overall healthcare costs for employers.